148.750

+1.780 (+1.21%)

Range 145.330 - 149.350   (2.77%)
Open 147.960
Previous Close 146.970
Buy Price 139.990
Buy Volume -
Sell Price 140.000
Sell Volume -
Volume 8,519,146
Value -
Remark
Measurement Type Value
EPS (USD) 5.739
Trailing EPS (USD) 6.516
NAV (USD) 23.265
Cash In Hand (USD) 5.895
Dividend 3.747
Dividend Yield (%) 2.55
PE 25.611
Trailing PE 22.557
Price / NAV 6.317
Price / Cash In Hand 24.933
Issued & Paid-up Shares 2,634,590,000
Treasury Shares 487,451,000
Market Cap (M) 387,205.692
Par Value (USD) n.a.
Beta - 75 Days -
R-Squared - 75 Days(%) -
Beta - 500 Days -
R-Squared - 500 Days(%) -
ISIN Code -
Under CPF Investment Scheme (CPFIS) No
Index Components
Delayed prices. Updated at 30 May 2020 04:00.
Data powered by

Upcoming Events

* Stock event date based on US timezone.

Earnings

Release Date 16 Jul 2020
View All Events

About JOHNSON & JOHNSON

Johnson & Johnson is a holding company. The Company is engaged in the research and development, manufacture and sale of a broad range of products in the health care field. The business of Johnson & Johnson is conducted by more than 275 operating companies located in 60 countries, including the United States, which sell products in virtually all countries throughout the world. In March 2013, Johnson & Johnson's Cordis Corporation announced the acquisition of Flexible Stenting Solutions, Inc. In June 2013, Johnson & Johnson announced the opening of the Johnson & Johnson Innovation center in Boston. In July 2014, Johnson & Johnson completed the divestiture of Ortho-Clinical Diagnostics business to Carlyle Group.

Loading Chart...


BUY
SELL
Stock
JOHNSON & JOHNSON(JNJ)
Target Price
Add Stop Loss
Time Frames
Editor
Share With: